The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Urine Steroid Metabolomics as a Biomarker Tool for Detecting Malignancy in Adrenal Tumors
Open accessAbstract
CONTEXT: Adrenal tumors have a prevalence of around 2% in the general population. Adrenocortical carcinoma (ACC) is rare but accounts for 2-11% of incidentally discovered adrenal masses. Differentiating ACC from adrenocortical adenoma (ACA) represents a diagnostic challenge in patients with adrenal incidentalomas, with tumor size, imaging, and even histology all providing unsatisfactory predictive values. OBJECTIVE: Here we developed a novel steroid metabolomic approach, mass spectrometry-based steroid profiling followed by machine learning analysis, and examined its diagnostic value for the detection of adrenal malignancy. DESIGN: Quantification of 32 distinct adrenal derived steroids was carried out by gas chromatography/mass spectrometry in 24-h urine samples from 102 ACA patients (age range 19-84 yr) and 45 ACC patients (20-80 yr). Underlying diagnosis was ascertained by histology and metastasis in ACC and by clinical follow-up [median duration 52 (range 26-201) months] without evidence of metastasis in ACA. Steroid excretion data were subjected to generalized matrix learning vector quantization (GMLVQ) to identify the most discriminative steroids. RESULTS: Steroid profiling revealed a pattern of predominantly immature, early-stage steroidogenesis in ACC. GMLVQ analysis identified a subset of nine steroids that performed best in differentiating ACA from ACC. Receiver-operating characteristics analysis of GMLVQ results demonstrated sensitivity = specificity = 90% (area under the curve = 0.97) employing all 32 steroids and sensitivity = specificity = 88% (area under the curve = 0.96) when using only the nine most differentiating markers. CONCLUSIONS: Urine steroid metabolomics is a novel, highly sensitive, and specific biomarker tool for discriminating benign from malignant adrenal tumors, with obvious promise for the diagnostic work-up of patients with adrenal incidentalomas.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Adrenal steroid production and metabolism are affected by sex, age, and BMI (342,345,346).”
From Adrenal incidentaloma (2020) · cites this paper as [342]
In the citing paper
“Twenty-four-hour urine steroid excretion analysis represents a more accurate estimate of total corticosteroid production and of adrenal precursor steroids and metabolites (342, 343) and therefore has significant potential in the assessment of adrenal diseases.”
From Adrenal incidentaloma (2020) · cites this paper as [342]
In the citing paper
“Twenty-four-hour urine steroid excretion analysis represents a more accurate estimate of total corticosteroid production and of adrenal precursor steroids and metabolites (342, 343) and therefore has significant potential in the assessment of adrenal diseases.”
From Adrenal incidentaloma (2020) · cites this paper as [342]
In the citing paper
“In particular, the cosecretion of a distinct combination of glucocorticoid and androgen metabolites is emerging as a sensitive diagnostic tool for ACC (342,348,349).”
From Adrenal incidentaloma (2020) · cites this paper as [342]
In the citing paper
“The majority of ACC patients (69%) showed androgen precursor excess, either combined with increased excretion of glucocorticoid precursors (36%) or both glucocorticoid and mineralocorticoid precursors (33%).”
From Adrenal incidentaloma (2020) · cites this paper as [342]
In the citing paper
“Using machine learning, the authors were able to identify that tetrahydro-11-deoxycortisol (THS), pregnenetriol (5-PT), and pregnenediol (5-PD) were the most discriminatory between ACC and ACA.”
From Adrenal incidentaloma (2020) · cites this paper as [342]
In the citing paper
“Urinary steroid profiling revealed distinct differences between adrenocortical adenomas and ACC patients (Fig. 10).”
From Adrenal incidentaloma (2020) · cites this paper as [342]
In the citing paper
“There was no effect of age, sex, tumor size, or presence of metastasis on the characteristics of the urine steroid metabolomes in ACC and ACA patients.”
From Adrenal incidentaloma (2020) · cites this paper as [342]
In the citing paper
“Studies have shown that ACCs have a distinct pattern of urinary corticosteroids, characterized by an excess of precursor steroid metabolites (Fig. 10 (342)).”
From Adrenal incidentaloma (2020) · cites this paper as [342]
In the citing paper
“Even when analyzing the ACC patients without evidence of hormone excess on routine biochemistry, urinary excretion of androgen, and glucocorticoid precursor metabolites remained significantly increased.”
From Adrenal incidentaloma (2020) · cites this paper as [342]
In the citing paper
“They reported that 27% of patients with ACC had no hormonal excess on routine biochemical testing.”
From Adrenal incidentaloma (2020) · cites this paper as [342]
In the citing paper
“By contrast, steroid precursor metabolite excretion in nonmalignant AI did not differ from healthy controls.”
From Adrenal incidentaloma (2020) · cites this paper as [342]
In the citing paper
“ACC patients had a significantly higher excretion of androgen precursor metabolites, metabolites of active androgens, deoxycorticosterone, and glucocorticoid precursor metabolites were significantly higher in ACC, as was free cortisol.”
From Adrenal incidentaloma (2020) · cites this paper as [342]
In the citing paper
“All studies identified THS as the most informative steroid marker indicative of ACC.”
From Adrenal incidentaloma (2020) · cites this paper as [342]
In the citing paper
“Particularly, the reoccurrence of presurgical steroid profiles may raise concern of relapse (95).”
From Adrenocortical carcinoma (2014) · cites this paper as [95]
In the citing paper
“As an example, this approach has been used for automating differentiation of adrenocortical carcinoma (ACC) from benign adrenocortical tumors based on the detection of a “malignant steroid fingerprint”, a distinct set of urine steroid metabolites characteristically increased in ACC [348].”
From Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: a comprehensive review (2019) · cites this paper as [348]
In the citing paper
“The urinary steroid metabolome represents the total of all steroid biosynthetic and metabolising pathways and has proven to be a specific and sensitive biomarker for the diagnosis of steroidogenic disease (Arlt et al., 2011).”
From Intracrine androgen biosynthesis, metabolism and action revisited (2018) · cites this paper as Arlt et al., 2011
In the citing paper
“AST and ETIO are measured as representatives of active androgens, while DHEA and 16αOH-DHEA are measured as representatives of direct androgen precursors (Arlt et al., 2011, Krone et al., 2010).”
From Intracrine androgen biosynthesis, metabolism and action revisited (2018) · cites this paper as Arlt et al., 2011
In the citing paper
“The combination of mass spectrometry–based steroid profiling with machine learning–based data analysis has created a powerful discovery tool, steroid metabolomics, highly suited as a diagnostic biomarker approach (1–4).”
From Steroid Metabolome Analysis in Disorders of Adrenal Steroid Biosynthesis and Metabolism (2019) · cites this paper as [1]
In the citing paper
“The combination of mass spectrometry–based steroid profiling with machine learning–driven analysis of the urinary steroid excretion data allowed for rapid detection of a “malignant steroid fingerprint” (Fig. 8E) (1) that can differentiate ACC from ACA with high sensitivity and specificity.”
From Steroid Metabolome Analysis in Disorders of Adrenal Steroid Biosynthesis and Metabolism (2019) · cites this paper as [1]
In the citing paper
“The steroid biomarkers that are most helpful at distinguishing ACCs from ACAs include the glucocorticoid precursor metabolite THS, and the androgen precursor metabolites of Preg and 17OHPreg, 5PD, and 5PT (1).”
From Steroid Metabolome Analysis in Disorders of Adrenal Steroid Biosynthesis and Metabolism (2019) · cites this paper as [1]
In the citing paper
“Additionally, recent retrospective studies employing GC-MS–based urine steroid profiling revealed that ACCs present a unique steroidogenic “signature” characterized by accumulation of steroid hormone precursors (1, 154, 155) (Fig. 8E).”
From Steroid Metabolome Analysis in Disorders of Adrenal Steroid Biosynthesis and Metabolism (2019) · cites this paper as [1]
In the citing paper
“Isolated autonomous androgen excess from the adrenal gland can very rarely occur in the context of benign ACAs (1).”
From Steroid Metabolome Analysis in Disorders of Adrenal Steroid Biosynthesis and Metabolism (2019) · cites this paper as [1]
In the citing paper
“Routine serum biochemistry detects steroid hormone excess in 60% to 70% of ACC patients, with glucocorticoid and androgen excess dominating (1, 188); however, urine GC-MS profiling demonstrated steroid excess in >90% (1).”
From Steroid Metabolome Analysis in Disorders of Adrenal Steroid Biosynthesis and Metabolism (2019) · cites this paper as [1]
In the citing paper
“Routine serum biochemistry detects steroid hormone excess in 60% to 70% of ACC patients, with glucocorticoid and androgen excess dominating (1, 188); however, urine GC-MS profiling demonstrated steroid excess in >90% (1).”
From Steroid Metabolome Analysis in Disorders of Adrenal Steroid Biosynthesis and Metabolism (2019) · cites this paper as [1]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2005) · Springer eBooks · doi:10.1007/0-387-27255-0_9 · Cited by 20,333
McCullagh, P., & Nelder, J. A. (1989) · doi:10.1007/978-1-4899-3242-6 · Cited by 16,836
Kohonen, T. (1995) · Springer series in information sciences · doi:10.1007/978-3-642-56927-2 · Cited by 16,032
The Incidentally Discovered Adrenal Mass
Young, W. F. (2007) · New England Journal of Medicine · doi:10.1056/nejmcp065470 · Cited by 1,090
Management of the clinically inapparent adrenal mass ("incidentaloma")
Grumbach, M. M., Biller, B. M. K., Braunstein, G. D., Campbell, K. K., Carney, J. A., Godley, P. A., Harris, E. L., Lee, J. K. T., Oertel, Y. C., Posner, M. C., et al. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-5-200303040-00013 · Cited by 945 · cited 4×
“The risk of malignancy increases with the diameter of the adrenal mass (1, 2, 8).”
BackgroundMethodInfluentialA Survey on Adrenal Incidentaloma in Italy
Mantero, F. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.2.637 · Cited by 907
Self-citationPathologic features of prognostic significance in adrenocortical carcinoma
Weiss, L. M., Medeiros, L. J., & Vickery, A. L. (1989) · The American Journal of Surgical Pathology · doi:10.1097/00000478-198903000-00004 · Cited by 818 · cited 2×
“a The Weiss system scores the presence or absence of nine histopathological features (Weiss score range 0–9); scores under 3 are indicative of a benign adrenal tumor, scores of 3 are borderline, and scores of 4 and above are indicative of malignancy (14).”
BackgroundThe clinically inapparent adrenal mass: update in diagnosis and management
Mansmann, G., Lau, J., Balk, E., Rothberg, M., Miyachi, Y., & Bornstein, S. R. (2004) · Endocrine Reviews · doi:10.1210/er.2002-0031 · Cited by 781
Adrenocortical Carcinoma: Clinical Update
Allolio, B., & Fassnacht, M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2639 · Cited by 775
Self-citationFassnacht, M., Johanssen, S., Quinkler, M., Bucsky, P., Willenberg, H. S., Beuschlein, F., Terzolo, M., Mueller, H., Hahner, S., Allolio, B., et al. (2009) · Cancer · doi:10.1002/cncr.24030 · Cited by 695
Self-citation
Flagged first, then by citations
Research works printed but not linked: 1
- Shackleton, 2011, GC/MS steroid profiling: diagnosis of disorders affecting steroid synthesis and metabolism, 789
Cited by
Sorted by citations
Lacroix, A., Feelders, R. A., Stratakis, C. A., & Nieman, L. K. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61375-1 · Cited by 1,777
Fassnacht, M., Arlt, W., Bancos, I., Dralle, H., Newell-Price, J., Sahdev, A., Tabarin, A., Terzolo, M., Tsagarakis, S., & Dekkers, O. M. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0467 · Cited by 1,566
Self-citationGlobal Disorders of Sex Development Update since 2006: Perceptions, Approach and Care
Lee, P. A., Nordenström, A., Houk, C. P., Ahmed, S. F., Auchus, R. J., Baratz, A. B., Dalke, K. B., Liao, L., Lin‐Su, K., Looijenga, L. H. J., et al. (2016) · Hormone Research in Paediatrics · doi:10.1159/000442975 · Cited by 1,292
Faßnacht, M., Dekkers, O. M., Else, T., Baudin, É., Berruti, A., de Krijger, R. R., Haak, H. R., Mihai, R., Assié, G., & Terzolo, M. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0608 · Cited by 976
Self-citationElse, T., Kim, A. C., Sabolch, A., Raymond, V. M., Kandathil, A., Caoili, E. M., Jolly, S., Miller, B. S., Giordano, T. J., & Hammer, G. D. (2014) · Endocrine Reviews · doi:10.1210/er.2013-1029 · Cited by 892
Faßnacht, M., Tsagarakis, S., Terzolo, M., Tabarin, A., Sahdev, A., Newell-Price, J. D. C., Pelsma, I. C. M., Marina, L., Lorenz, K., Bancos, I., et al. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvad066 · Cited by 849
Self-citationSchiffer, L., Barnard, L., Baranowski, E. S., Gilligan, L. C., Taylor, A. E., Arlt, W., Shackleton, C. H. L., & Storbeck, K.-H. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.105439 · Cited by 450
“As an example, this approach has been used for automating differentiation of adrenocortical carcinoma (ACC) from benign adrenocortical tumors based on the detection of a “malignant steroid fingerprint”, a distinct set of urine steroid metabolites characteristically increased in ACC [348].”
Self-citationFaßnacht, M., Assié, G., Baudin, É., Eisenhofer, G., de la Fouchardière, C., Haak, H. R., de Krijger, R. R., Porpiglia, F., Terzolo, M., & Berruti, A. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.08.2099 · Cited by 446
Self-citationUpdate in Adrenocortical Carcinoma
Faßnacht, M., Kroiß, M., & Allolio, B. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3020 · Cited by 414
Self-citationSherlock, M., Scarsbrook, A., Abbas, A., Fraser, S., Limumpornpetch, P., Dineen, R., & Stewart, P. M. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnaa008 · Cited by 347
“The study by Arlt et al. (342) assessed the 24-hour urinary steroid metabolome using GC-MS in 102 patients with benign adrenal adenomas and 45 patients with ACC.”
BackgroundMethodInfluentialSelf-citationKerkhofs, T. M. A., Verhoeven, R. H. A., van der Zwan, J. M., Dieleman, J. P., Kerstens, M. N., Links, T. P., van de Poll-Franse, L. V., & Haak, H. R. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.02.034 · Cited by 343
Metabolomics in cancer biomarker discovery: Current trends and future perspectives
Armitage, E. G., & Barbas, C. (2013) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2013.08.041 · Cited by 343
Adrenal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Berruti, A., Baudin, É., Gelderblom, H. A. J., Haak, H. R., Porpiglia, F., Faßnacht, M., & Pentheroudakis, G. (2012) · Annals of Oncology · doi:10.1093/annonc/mds231 · Cited by 330
Mass spectrometry and immunoassay: how to measure steroid hormones today and tomorrow
Taylor, A. E., Keevil, B., & Huhtaniemi, I. T. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0338 · Cited by 320
Self-citationSteroid metabolome analysis reveals prevalent glucocorticoid excess in primary aldosteronism
Arlt, W., Lang, K., Sitch, A. J., Dietz, A. S., Rhayem, Y., Bancos, I., Feuchtinger, A., Chortis, V., Gilligan, L. C., Ludwig, P., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.93136 · Cited by 281
Self-citationBancos, I., Taylor, A. E., Chortis, V., Sitch, A. J., Jenkinson, C., Davidge-Pitts, C. J., Lang, K., Tsagarakis, S., Macech, M., Riester, A., et al. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30218-7 · Cited by 250
Self-citationAdrenocortical carcinoma (ACC): diagnosis, prognosis, and treatment
Libé, R. (2015) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2015.00045 · Cited by 233
Self-citationGaujoux, S., Mihai, R., Carnaille, B. M. L., Dousset, B. E., Fiori, C., Porpiglia, F., Hellman, P., Iacobone, M., Kraimps, J. L., Donatini, G., et al. (2017) · British journal of surgery · doi:10.1002/bjs.10414 · Cited by 226
Intracrine androgen biosynthesis, metabolism and action revisited
Schiffer, L., Arlt, W., & Storbeck, K.-H. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.08.016 · Cited by 217
“tive biomarker for the diagnosis of steroidogenic disease (Arlt et al., 2011).”
Self-citationMetabolomics and Proteomics in Type 2 Diabetes
Chen, Z., & Gerszten, R. E. (2020) · Circulation Research · doi:10.1161/circresaha.120.315898 · Cited by 214
Approach to the Patient With Adrenal Incidentaloma
Bancos, I., & Prete, A. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab512 · Cited by 201
Metabolomics for the masses: The future of metabolomics in a personalized world
Trivedi, D. K., Hollywood, K. A., & Goodacre, R. (2017) · European Journal of Molecular & Clinical Medicine · doi:10.1016/j.nhtm.2017.06.001 · Cited by 199
Eisenhofer, G., Peitzsch, M., Kaden, D., Langton, K., Pamporaki, C., Masjkur, J., Tsatsaronis, G., Mangelis, A., Williams, T. A., Reincke, M., et al. (2017) · Clinica Chimica Acta · doi:10.1016/j.cca.2017.05.002 · Cited by 171
Peitzsch, M., Dekkers, T., Haase, M., Sweep, F. C. G. J., Quack, I., Antoch, G., Siegert, G., Lenders, J. W. M., Deinum, J., Willenberg, H. S., et al. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.10.006 · Cited by 169
Prototype‐based models in machine learning
Biehl, M. L., Hammer, B., & Villmann, T. (2016) · Wiley Interdisciplinary Reviews Cognitive Science · doi:10.1002/wcs.1378 · Cited by 166
Self-citationCancer metabolomic markers in urine: evidence, techniques and recommendations
Dinges, S. S., Hohm, A., Vandergrift, L. A., Nowak, J., Habbel, P., Kaltashov, I. A., & Cheng, L. L. (2019) · Nature Reviews Urology · doi:10.1038/s41585-019-0185-3 · Cited by 162
Eisenhofer, G., Dekkers, T., Peitzsch, M., Dietz, A., Bidlingmaier, M., Treitl, M., Williams, T. A., Bornstein, S. R., Haase, M., Rump, L. C., et al. (2016) · Clinical Chemistry · doi:10.1373/clinchem.2015.251199 · Cited by 159
Chortis, V., Taylor, A. E., Schneider, P., Tomlinson, J. W., Hughes, B. A., O'Neil, D. M., Libé, R., Allolio, B., Bertagna, X., Bertherat, J., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2851 · Cited by 154
Self-citationThe role of surgery in the management of recurrent adrenocortical carcinoma
Erdogan, I., Deutschbein, T., Jurowich, C., Kroiss, M., Ronchi, C., Quinkler, M., Waldmann, J., Willenberg, H. S., Beuschlein, F., Fottner, C., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2559 · Cited by 154
Self-citationLC–MS/MS analysis of steroids in the clinical laboratory
Keevil, B. G. (2016) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2016.04.009 · Cited by 149
“Nonfunctional” Adrenal Tumors and the Risk for Incident Diabetes and Cardiovascular Outcomes
Lopez, D., Luque-Fernández, M. Á., Steele, A. E., Adler, G. K., Turchin, A., & Vaidya, A. (2016) · Annals of Internal Medicine · doi:10.7326/m16-0547 · Cited by 149
Review of Mass Spectrometry–Based Metabolomics in Cancer Research
Liesenfeld, D. B., Habermann, N., Owen, R. W., Scalbert, A., & Ulrich, C. M. (2013) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-0584 · Cited by 150
Steroid Metabolome Analysis in Disorders of Adrenal Steroid Biosynthesis and Metabolism
Storbeck, K.-H., Schiffer, L., Baranowski, E. S., Chortis, V., Prete, A., Barnard, L., Gilligan, L. C., Taylor, A. E., Idkowiak, J., Arlt, W., et al. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00262 · Cited by 141
Self-citationAdrenocortical carcinoma — towards genomics guided clinical care
Crona, J., & Beuschlein, F. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0221-7 · Cited by 142
Mild autonomous cortisol secretion: pathophysiology, comorbidities and management approaches
Prete, A., & Bancos, I. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-024-00984-y · Cited by 130
Dai, W., Huang, Q., Yin, P., Li, J., Zhou, J., Kong, H., Zhao, C., Lu, X., & Xu, G. (2012) · Analytical Chemistry · doi:10.1021/ac301984t · Cited by 119
Iñiguez‐Ariza, N. M., Kohlenberg, J. D., Delivanis, D. A., Hartman, R. P., Dean, D. S., Thomas, M. A., Shah, M. Z., Herndon, J. S., McKenzie, T. J., Arlt, W., et al. (2017) · Mayo Clinic Proceedings Innovations Quality & Outcomes · doi:10.1016/j.mayocpiqo.2017.11.002 · Cited by 118
Self-citationEisenhofer, G., Durán, C., Cannistraci, C. V., Peitzsch, M., Williams, T. A., Riester, A., Burrello, J., Buffolo, F., Prejbisz, A., Beuschlein, F., et al. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.16209 · Cited by 116
Elbelt, U., Trovato, A., Kloth, M. T., Gentz, E., Finke, R., Spranger, J., Galas, D. J., Weber, S. N., Wolf, C., König, K., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2648 · Cited by 120
Self-citationRapid control of severe neoplastic hypercortisolism with metyrapone and ketoconazole
Corcuff, J., Young, J., Masquefa-Giraud, P., Chanson, P., Baudin, É., & Tabarin, A. (2015) · European Journal of Endocrinology · doi:10.1530/eje-14-0913 · Cited by 114
Role of biomarker tests for diagnosis of neuroendocrine tumours
Hofland, J., Zandee, W. T., & de Herder, W. W. (2018) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0082-5 · Cited by 113
Hines, J. M., Bancos, I., Bancos, C., Singh, R. D., Avula, A. V., Young, W. F., Grebe, S. K., & Singh, R. J. (2017) · Clinical Chemistry · doi:10.1373/clinchem.2017.271106 · Cited by 111
A 13-steroid serum panel based on LC-MS/MS: use in detection of adrenocortical carcinoma
Taylor, D. R., Ghataore, L., Couchman, L., Vincent, R. P., Whitelaw, B., Lewis, D., Diaz-Cano, S., Galata, G., Schulte, K.-M., Aylwin, S., et al. (2017) · Clinical Chemistry · doi:10.1373/clinchem.2017.277624 · Cited by 109
Diagnostic value of urinary steroid profiling in the evaluation of adrenal tumors
Kerkhofs, T. M. A., Kerstens, M. N., Kema, I. P., Willems, T. P., & Haak, H. R. (2015) · Hormones and Cancer · doi:10.1007/s12672-015-0224-3 · Cited by 102
Analysis of circulating microRNAs in adrenocortical tumors
Szabó, D. R., Luconi, M., Szabó, P. M., Tóth, M., Szücs, N., Horányi, J., Nagy, Z., Mannelli, M., Patócs, A., Rácz, K., et al. (2013) · Laboratory Investigation · doi:10.1038/labinvest.2013.148 · Cited by 102
Jeanneret, F., Tonoli, D., Rossier, M. F., Saugy, M., Boccard, J., & Rudaz, S. L. (2015) · Journal of Chromatography A · doi:10.1016/j.chroma.2015.07.008 · Cited by 100
Plasma Steroid Metabolome Profiling for Diagnosis and Subtyping Patients with Cushing Syndrome
Eisenhofer, G., Masjkur, J. R., Peitzsch, M., Dalmazi, G. D., Bidlingmaier, M., Grüber, M., Fazel, J., Oßwald, A., Beuschlein, F., & Reincke, M. (2017) · Clinical Chemistry · doi:10.1373/clinchem.2017.282582 · Cited by 99
Prete, A., Taylor, A. E., Bancos, I., Smith, D. J., Foster, M. A., Kohler, S., Fazal-Sanderson, V., Komninos, J., O’Neil, D. M., Vassiliadi, D. A., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa133 · Cited by 96
Self-citationDerivatization of Steroids in Biological Samples for GC–MS and LC–MS Analyses
Marcos, J., & Pozo, Ó. J. (2015) · Bioanalysis · doi:10.4155/bio.15.176 · Cited by 95
Urine steroid metabolomics as a novel tool for detection of recurrent adrenocortical carcinoma
Chortis, V., Bancos, I., Nijman, T., Gilligan, L. C., Taylor, A. E., Ronchi, C. L., O’Reilly, M. W., Schreiner, J., Asia, M., Riester, A., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz141 · Cited by 93
Self-citationToward a Standardized Strategy of Clinical Metabolomics for the Advancement of Precision Medicine
Long, N. P., Nghi, T. D., Kang, Y. P., Anh, N. H., Kim, H. M., Park, S. K., & Kwon, S. W. (2020) · Metabolites · doi:10.3390/metabo10020051 · Cited by 95
Approach to androgen excess in women: Clinical and biochemical insights
Cussen, L., McDonnell, T., Bennett, G., Thompson, C. J., Sherlock, M., & O’Reilly, M. (2022) · Clinical Endocrinology · doi:10.1111/cen.14710 · Cited by 92
Bertherat, J. Y., Bourdeau, I., Bouys, L., Chasseloup, F., Kamenický, P., & Lacroix, A. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnac034 · Cited by 92
Self-citationPlasma steroid metabolome profiling for the diagnosis of adrenocortical carcinoma
Schweitzer, S., Kunz, M., Kurlbaum, M., Vey, J., Kendl, S., Deutschbein, T., Hahner, S., Fassnacht, M., Dandekar, T., & Kroiss, M. (2019) · European Journal of Endocrinology · doi:10.1530/eje-18-0782 · Cited by 85
Self-citationMcDonald, J. G., Matthew, S., & Auchus, R. J. (2011) · Hormones and Cancer · doi:10.1007/s12672-011-0099-x · Cited by 85
Diagnosis and management of primary bilateral macronodular adrenal hyperplasia
Vassiliadi, D. A., & Tsagarakis, S. (2019) · Endocrine Related Cancer · doi:10.1530/erc-19-0240 · Cited by 83
Dennedy, M. C., Annamalai, A. K., Smith, O. P., Freeman, N., Vengopal, K., Graggaber, J., Koulouri, O., Powlson, A., Shaw, A., Halsall, D. J., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2718 · Cited by 83
Di Dalmazi, G., Fanelli, F., Mezzullo, M., Casadio, E., Rinaldi, E., Garelli, S., Giampalma, E., Mosconi, C., Golfieri, R., Vicennati, V., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1992 · Cited by 82
Williams, A. R., Hammer, G. D., & Else, T. (2014) · European Journal of Endocrinology · doi:10.1530/eje-13-1033 · Cited by 82
Genetics of tumors of the adrenal cortex
Bonnet-Serrano, F., & Bertherat, J. (2018) · Endocrine Related Cancer · doi:10.1530/erc-17-0361 · Cited by 80
Self-citationThe Evaluation of Incidentally Discovered Adrenal Masses
Vaidya, A., Hamrahian, A. H., Bancos, I., Fleseriu, M., & Ghayee, H. K. (2019) · Endocrine Practice · doi:10.4158/dscr-2018-0565 · Cited by 79
Gender-Specific Differences in Skeletal Muscle 11β-HSD1 Expression Across Healthy Aging
Hassan-Smith, Z. K., Morgan, S., Sherlock, M., Hughes, B. A., TAYLOR, A. E. R., Lavery, G. G., Tomlinson, J., & Stewart, P. M. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1516 · Cited by 76
Self-citationShackleton, C., Pozo, O. J., & Marcos, J. (2018) · Journal of the Endocrine Society · doi:10.1210/js.2018-00135 · Cited by 75
Self-citationComprehensive Targeted Metabolomic Assay for Urine Analysis
Zheng, J., Zhang, L., Johnson, M., Mandal, R., & Wishart, D. S. (2020) · Analytical Chemistry · doi:10.1021/acs.analchem.0c01682 · Cited by 75
From a single steroid to the steroidome: Trends and analytical challenges
Olesti, E., Boccard, J., Visconti, G., González‐Ruiz, V., & Rudaz, S. L. (2020) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2020.105797 · Cited by 74
Gaikwad, N. W. (2013) · Analytical Chemistry · doi:10.1021/ac400016e · Cited by 72
Treatment of Adrenocortical Carcinoma
Vaidya, A., Nehs, M. A., & Kilbridge, K. L. (2019) · Surgical pathology clinics · doi:10.1016/j.path.2019.08.010 · Cited by 71
Kiseljak-Vassiliades, K., Bancos, I., Hamrahian, A., Habra, M. A., Vaidya, A., Levine, A. C., & Else, T. (2020) · Endocrine Practice · doi:10.4158/dscr-2020-0567 · Cited by 66
Baudin, É. (2015) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2015.03.001 · Cited by 66
Lorenz, K., Langer, P., Niederle, B., Alesina, P. F., Holzer, K., Nies, C., Musholt, T., Goretzki, P. E., Rayes, N., Quinkler, M. O., et al. (2019) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-019-01768-z · Cited by 66
The Low-Renin Hypertension Phenotype: Genetics and the Role of the Mineralocorticoid Receptor
Baudrand, R. F., & Vaidya, A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020546 · Cited by 64
Velikanova, L. I., Shafigullina, Z. R., Lisitsin, A. A., Vorokhobina, N. V., Grigoryan, K., Kukhianidze, E. A., Strelnikova, E. G., Krivokhizhina, N. S., Krasnov, L. M., Fedorov, E. A., et al. (2016) · Hormones and Cancer · doi:10.1007/s12672-016-0267-0 · Cited by 62
Perge, P., Butz, H., Pezzani, R., Bancos, I., Nagy, Z., Pálóczi, K., Nyírő, G., Decmann, Á., Pap, E., Luconi, M., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-05777-0 · Cited by 62
Stigliano, A., Chiodini, I., Giordano, R., Faggiano, A., Canu, L., Casa, S. D., Loli, P., Luconi, M., Mantero, F., & Terzolo, M. (2015) · Journal of Endocrinological Investigation · doi:10.1007/s40618-015-0349-9 · Cited by 61
Self-citation17-Hydroxyprogesterone in children, adolescents and adults
Honour, J. W. (2014) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/0004563214529748 · Cited by 68
Using Machine Learning to Aid the Interpretation of Urine Steroid Profiles
Wilkes, E. H., Rumsby, G., & Woodward, G. (2018) · Clinical Chemistry · doi:10.1373/clinchem.2018.292201 · Cited by 60
Shariq, O. A., & McKenzie, T. J. (2021) · Therapeutic Advances in Chronic Disease · doi:10.1177/20406223211033103 · Cited by 63
Future directions in the diagnosis and medical treatment of adrenocortical carcinoma
Creemers, S. G., Hofland, L. J., Korpershoek, E., Franssen, G. J. H., van Kemenade, F. J., de Herder, W. W., & Feelders, R. A. (2015) · Endocrine Related Cancer · doi:10.1530/erc-15-0452 · Cited by 61
Analysis of Flow Cytometry Data by Matrix Relevance Learning Vector Quantization
Biehl, M. L., Bunte, K., & Schneider, P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059401 · Cited by 57
Self-citationDiagnosis, treatment and outcome of adrenocortical cancer
Mihai, R. (2015) · British journal of surgery · doi:10.1002/bjs.9743 · Cited by 56
Artificial Intelligence and Machine Learning in Endocrinology and Metabolism: The Dawn of a New Era
Gubbi, S., Hamet, P., Tremblay, J., Koch, C. A., & Hannah‐Shmouni, F. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00185 · Cited by 56
Libé, R., & Huillard, O. (2023) · Cancer Treatment and Research Communications · doi:10.1016/j.ctarc.2023.100759 · Cited by 55
Self-citationTreating Primary Aldosteronism-Induced Hypertension: Novel Approaches and Future Outlooks
Mullen, N., Curneen, J. M. G., Donlon, P. T., Prakash, P., Bancos, I., Gurnell, M., & Dennedy, M. C. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnad026 · Cited by 55
Ackermann, D., Groessl, M., Pruijm, M. T., Ponte, B., Escher, G., d’Uscio, C. H., Guessous, I., Ehret, G., Péchère-Bertschi, A., Martin, P., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0214549 · Cited by 54
Recent evolutions of machine learning applications in clinical laboratory medicine
Bruyne, S. D., Speeckaert, M. M., Biesen, W. V., & Delanghe, J. (2020) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2020.1828811 · Cited by 53
Multi-steroid profiling by UHPLC-MS/MS with post-column infusion of ammonium fluoride
Schiffer, L., Shaheen, F., Gilligan, L. C., Storbeck, K.-H., Hawley, J. M., Keevil, B. G., Arlt, W., & Taylor, A. E. (2022) · Journal of Chromatography B · doi:10.1016/j.jchromb.2022.123413 · Cited by 52
Self-citationAdvances in the analytical methodologies: profiling steroids in familiar pathways-challenging dogmas
Bloem, L. M., Storbeck, K.-H., Swart, P., du Toit, T., Schloms, L., & Swart, A. C. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2015.04.009 · Cited by 52
Plasma Steroid Profiling in Patients With Adrenal Incidentaloma
Berke, K., Constantinescu, G. A., Masjkur, J. R., Kimpel, O., Dischinger, U., Peitzsch, M., Kwapiszewska, A., Dobrowolski, P., Nölting, S., Reincke, M., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab751 · Cited by 52
Self-citationPlasma Steroid Profiles in Subclinical Compared With Overt Adrenal Cushing Syndrome
Masjkur, J. R., Grüber, M., Peitzsch, M., Kaden, D., Dalmazi, G. D., Bidlingmaier, M., Zopp, S., Langton, K., Fazel, J., Beuschlein, F., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-02349 · Cited by 51
Lavery, G. G., Idkowiak, J., Sherlock, M., Bujalska, I., Ride, J. P., Saqib, K., Hartmann, M. F., Hughes, B., Wudy, S. A., De Schepper, J., et al. (2013) · European Journal of Endocrinology · doi:10.1530/eje-12-0628 · Cited by 50
Self-citationAdrenocortical Carcinoma with Hypercortisolism
Puglisi, S., Perotti, P., Pia, A. R., Reimondo, G., & Terzolo, M. (2018) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2018.02.003 · Cited by 50
Self-citationStorbeck, K.-H., Gilligan, L., Jenkinson, C., Baranowski, E. S., Quanson, J. L., Arlt, W., & Taylor, A. E. (2018) · Journal of Chromatography B · doi:10.1016/j.jchromb.2018.03.033 · Cited by 49
Self-citationPapanastasiou, L., Alexandraki, K., Androulakis, I. I., Fountoulakis, S., Kounadi, T., Markou, Α., Tsiavos, V., Samara, C., Papaioannou, T., Piaditis, G. P., et al. (2016) · Clinical Endocrinology · doi:10.1111/cen.13294 · Cited by 49
Rister, A. L., Martin, T. L., & Dodds, E. D. (2018) · Journal of the American Society for Mass Spectrometry · doi:10.1007/s13361-018-2085-9 · Cited by 48
Recent advances in adrenocortical carcinoma in adults
Bourdeau, I., MacKenzie-Feder, J., & Lacroix, A. (2013) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e3283602274 · Cited by 47
Modern management of mild autonomous cortisol secretion
Delivanis, D. A., Athimulam, S., & Bancos, I. (2019) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1551 · Cited by 46
Current management options for recurrent adrenocortical carcinoma
Sidhu, S. B., Glover, A. R., Ip, Zhao, J., Soon, & Robinson (2013) · OncoTargets and Therapy · doi:10.2147/ott.s34956 · Cited by 46
Arruda, M., Cavalari, E. M. R., de Paula, M. P., de Morais, F. F. C., Bilro, G. F., Coelho, M. C. A., de Morais, N. A. D. O. E. S., Choeri, D., Moraes, A. B., & Neto, L. V. (2017) · Journal of Human Hypertension · doi:10.1038/s41371-017-0011-4 · Cited by 46
Steroid biomarkers in human adrenal disease
Rege, J., Turcu, A. F., Else, T., Auchus, R. J., & Rainey, W. E. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.01.018 · Cited by 47
Mizdrak, M., Kurir, T. T., & Božić, J. (2021) · Biomedicines · doi:10.3390/biomedicines9020174 · Cited by 44
Metadata
- Authors
- Arlt, W., Biehl, M., Taylor, A. E., Hahner, S., Libé, R., Hughes, B. A., Schneider, P., Smith, D. J., Stiekema, H., Krone, N., Porfiri, E., Opocher, G., Bertherat, J., Mantero, F., Allolio, B., Terzolo, M., Nightingale, P., Shackleton, C. H. L., Bertagna, X., Fassnacht, M., & Stewart, P. M.
- Affiliations
- University of Birmingham (GB)
- University of Groningen (NL)
- University of Würzburg (DE)
- Inserm (FR)
- University of Padua (IT)
- Department of Endocrinology (R.L., J.B., X.B.), INCa-COMETE, Cochin Hospital, Institut Cochin, Institut National de la Santé et de la Recherche Médicale Unité 1016, René Descartes University, 75006 Paris, France
- University of Turin (IT)
- National Health Service (GB)
- Corresponding author
- Arlt, Wiebke
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2011-12-01
- Volume
- 96
- Issue
- 12
- Pages
- 3775-3784
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC3232629
- OpenAlex
- W1991016861
- Cited by
- 458
- References
- 38
- Citations by year
- 2026: 19 · 2025: 28 · 2024: 31 · 2023: 26 · 2022: 31 · 2021: 28 · 2020: 41 · 2019: 48 · 2018: 35 · 2017: 30 · 2016: 30 · 2015: 41 · 2014: 24 · 2013: 21 · 2012: 21
- FWCI
- 22.57
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (publishedVersion, cc-by-nc)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion, other-oa)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
- Online Publication Service of Würzburg University (Würzburg University) (submittedVersion, cc-by-nc)
- Spiral (Imperial College London) (submittedVersion, cc-by-nc)
- Padua Research Archive (University of Padova) (submittedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, other-oa)
- Funders
- National Institute for Health and Care Research (NF-SI-0508-10356)
- European Commission (259735)
- European Science Foundation
- Medical Research Council (G0801473)
- European Social Fund
- Topics
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolomics and Mass Spectrometry Studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- adrenocortical carcinoma, adrenal adenoma, adrenal incidentaloma, steroid profiling, machine learning biomarkers, benign versus malignant differentiation
- MeSH terms
- Adrenal Cortex Hormones, Adrenal Cortex Neoplasms, Adult, Aged, Aged, 80 and over, Diagnosis, Differential, Female, Humans, Male, Middle Aged, Mass Spectrometry, Biomarkers, Adrenocortical Adenoma, Adrenocortical Carcinoma, Metabolomics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
